Related Experiment Video
Updated: Jun 7, 2025

11:11
Longitudinal Measurement of Extracellular Matrix Rigidity in 3D Tumor Models Using Particle-tracking Microrheology
Published on: June 10, 2014
11.5K
Understanding and measuring mechanical signals in the tumor stroma
Fàtima de la Jara Ortiz1, Chiara Cimmino2,3, Maurizio Ventre2,3,4
1Department of Medical BioSciences, Radboud University Medical Center, Nijmegen, The Netherlands.
FEBS Open Bio
|November 11, 2024
Summary
The tumor microenvironment
Area of Science:
- Oncology and Cancer Biology
- Biomedical Engineering
- Biophysics
Background:
- The tumor microenvironment (TME) exhibits immune suppressive properties, particularly in solid tumors with dense stroma.
- Tumor stroma mechanics, governed by extracellular matrix (ECM) composition and architecture, significantly influence the TME.
- Cancer-associated fibroblasts (CAFs) are key players in ECM remodeling, with increasing research into their heterogeneity and functions.
Purpose of the Study:
- To review recent findings on cancer-associated fibroblast (CAF) subtypes and their functions.
- To discuss the development and application of 3D models for studying tumor stroma mechanics in vitro.
- To highlight quantitative techniques for measuring tissue mechanical properties across different scales.
Main Methods:
- Literature review of recent findings on CAF heterogeneity and function.
- Discussion of 3D in vitro models for simulating tumor stroma mechanics.
- Overview of quantitative techniques for mechanical property measurement.
Main Results:
- Recent research identifies distinct CAF subtypes with specific roles in tumor progression.
- 3D models offer valuable platforms for investigating the impact of stroma mechanics on tumor biology.
- Various quantitative methods exist for assessing tissue stiffness and composition at multiple scales.
Conclusions:
- Understanding CAF heterogeneity and tumor stroma mechanics is crucial for cancer research.
- Mechanical properties of the tumor stroma have diagnostic and prognostic implications.
- Targeting stromal components presents a promising avenue for novel anti-tumor therapies.

